Bettina Weigelin

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 12

Top Topics

Pseudomonas Aeruginosa

Regulatory T Cells

Small Cell Lung Cancer

Top Venues

Disease models & mechanisms

Nature communications

Cancer immunology research

This page only lists publications with an associated author ORCID identifier.

Publications

Jasmin Scheurer, Birgit Sauer, Jule Focken, Martina Giampetraglia, Annika Jäger, Christian M Schürch, Bettina Weigelin, Birgit Schittek
Histological and functional characterization of 3D human skin models mimicking the inflammatory skin diseases psoriasis and atopic dermatitis. Disease models & mechanisms 17 (1) (2024)
Peter Friedl, Bettina Weigelin
The value of slow-burning science: an interview with Peter Friedl and Bettina Weigelin. Disease models & mechanisms 17 (7) (2024)
Peter Friedl, Bettina Weigelin
The value of slow-burning science: an interview with Peter Friedl and Bettina Weigelin. Disease models & mechanisms 17 (7) (2024)
Jasmin Scheurer, Birgit Sauer, Jule Focken, Martina Giampetraglia, Annika Jäger, Christian M Schürch, Bettina Weigelin, Birgit Schittek
Histological and functional characterization of 3D human skin models mimicking the inflammatory skin diseases psoriasis and atopic dermatitis. Disease models & mechanisms 17 (1) (2024)
Jasmin Scheurer, Birgit Sauer, Jule Focken, Martina Giampetraglia, Annika Jäger, Christian M Schürch, Bettina Weigelin, Birgit Schittek
Histological and functional characterization of 3D human skin models mimicking the inflammatory skin diseases psoriasis and atopic dermatitis. Disease models & mechanisms 17 (1) (2024)
Peter Friedl, Bettina Weigelin
The value of slow-burning science: an interview with Peter Friedl and Bettina Weigelin. Disease models & mechanisms 17 (7) (2024)
Jasmin Scheurer, Birgit Sauer, Jule Focken, Martina Giampetraglia, Annika Jäger, Christian M Schürch, Bettina Weigelin, Birgit Schittek
Histological and functional characterization of 3D human skin models mimicking the inflammatory skin diseases psoriasis and atopic dermatitis. Disease models & mechanisms 17 (1) (2024)
Jeroen Slaats, Esther Wagena, Daan Smits, Annemarie A Berends, Ella Peters, Gert-Jan Bakker, Merijn van Erp, Bettina Weigelin, Gosse J Adema, Peter Friedl
Adenosine A2a Receptor Antagonism Restores Additive Cytotoxicity by Cytotoxic T Cells in Metabolically Perturbed Tumors. Cancer immunology research 10 (12) (2022)
Jeroen Slaats, Cindy E Dieteren, Esther Wagena, Louis Wolf, Tonke K Raaijmakers, Jeroen van der Laak, Carl G Figdor, Bettina Weigelin, Peter Friedl
Metabolic Screening of Cytotoxic T-cell Effector Function Reveals the Role of CRAC Channels in Regulating Lethal Hit Delivery. Cancer immunology research 9 (8) (2021)
Richard J Beck, Bettina Weigelin, Joost B Beltman
Mathematical Modelling Based on In Vivo Imaging Suggests CD137-Stimulated Cytotoxic T Lymphocytes Exert Superior Tumour Control Due to an Enhanced Antimitotic Effect on Tumour Cells. Cancers 13 (11) (2021)
Bettina Weigelin, Annemieke Th den Boer, Esther Wagena, Kelly Broen, Harry Dolstra, Rob J De Boer, Carl G Figdor, Johannes Textor, Peter Friedl
Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity. Nature communications 12 (1) (2021)
Clemens Hinterleitner, Jasmin Strähle, Elke Malenke, Martina Hinterleitner, Melanie Henning, Marco Seehawer, Tatjana Bilich, Jonas Heitmann, Martina Lutz, Sven Mattern, Sophia Scheuermann, Marius Horger, Stefanie Maurer, Juliane Sarah Walz, Falko Fend, Rupert Handgretinger, Christian Martin Seitz, Bettina Weigelin, Stephan Singer, Helmut Salih, Oliver Borst, Hans-Georg Kopp, Lars Zender
Platelet PD-L1 reflects collective intratumoral PD-L1 expression and predicts immunotherapy response in non-small cell lung cancer. Nature communications 12 (1) (2021)